iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding iSpecimen Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 6 | 7 | +1 |
| Shares | 38.9K | 35.7K | −3.17K (−8.2%) |
| Value | $182.9K | $94.9K | −$88.0K (−48.1%) |
New holders (3)
Institutions that held iSpecimen Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 21,800 | $57.9K | 0.00% |
| Sachetta, LLC | 2 | $6 | 0.00% |
| SBI Securities Co., Ltd. | 2 | $5 | 0.00% |
Sold out (2)
Institutions that held iSpecimen Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Jane Street Group, LLC | 21,895 | $102.9K |
| FNY Investment Advisers, LLC | 11,500 | $54.0K |